Tony Lemmo

Tony has over 25 years of experience bringing platform technologies to the life sciences, diagnostics and pharmaceutical industries. He currently serves as the CEO and President of BioDot Inc., the market leader in automated, high-throughput ultra-low volume dispensing systems for the manufacturing of today’s most advanced diagnostics. BioDot manufactures the dispensing technology currently used by more than 80 diagnostics manufacturers worldwide to make COVID-19 antigen, antibody and PCR tests.